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Abstract
Background: Yersinia pseudotuberculosis generally infects the gastrointestinal tract and causes enteropathy
symptoms suggesting infection. Y. pseudotuberculosis infections are often complicated with intraceliac
lymphoadenopathy mimicking malignant lymphoma. This is a first case of Yersinia pseudotuberculosis enteropathy
mimicking enteropathic γδ T-cell lymphoma. This case highlighted the γδ T-cell reaction to Yersinia enterocolitis
sometimes mimicking malignant lymphoma clinically.
Case presentation: A 72-year-old female was referred to our institute due to abdominal pain with skin rush, fever and
diarrhea. Computed tomography (CT) scanning revealed mucosal swelling of the cecum with enlargement of regional
lymph nodes. Laboratory data showed elevated CRP (7.74 mg/dL), an increased level of soluble interleukin-2 receptor
(sIL-2R 3095 IU/mL), and CD3+ γδ T-cell circulation in peripheral blood and bone marrow (10.9% and 3.9%, respectively).
Increased proportions of γδ T-cells supported the diagnosis of malignant lymphoma. Colonoscopy demonstrated
hemorrhagic mucosal erosion with partial ulceration, and the subsequent pathological findings at the inflammation site
suggested malignant lymphoma histopathology in the colon. These objective findings were entirely consistent with
enteropathic γδ T-cell lymphoma. Thereafter, however, the microbiological results of the patient’s stool at admission
showed Yersinia pseudotuberculosis, and she was diagnosed as having Yersinia enterocolitis. All abnormal findings
including subjective symptoms were in remission or mitigated within 2 weeks after her onset. Even the γδ T-cell
circulation disappeared (0.04% in peripheral blood), and we speculate that those cells were a reaction to the Yersinia
infection.
Conclusion: In this case, a differential diagnosis included infectious enterocolitis from other immunogenic or
malignant diseases. Although a measurement of sIL-2R is critical in differentiating malignant lymphoma in patients
suffering with lymph adenopathy, that is not confirmative. This patient’s case indicates that T cells expressing the γδ
T-cell receptor might be associated with the acute and late phase reactions, in which T cells play a role in the
construction of granulomas and the establishment of sequelae.
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Background
Yersinia pseudotuberculosis is a Gram-negative bacillus
organism that can cause gastrointenstinal tract infec-
tions. Y. pseudotuberculosis infections are often com-
plicated with intraceliac lymphoadenopathy in humans.
Some cases progress to severe local inflammation with
lymph node swelling, mimicking malignant lymphoma.
In light of these characteristics, it is occasionally difficult
to differentiate Yersinia enterocolitis from malignant
lymphoma.
Most Yersinia infections arise from food contami-
nation derived from water or raw pork. Notably, Y. pseu-
dotuberculosis is known to cause the development of
pseudotuberculotic mucosal lesions in the intestine or
colon. The pathological features are characterized by an
infiltration of various inflammatory cells, including lym-
phocytes and histiocytes, into necrotic granulomatous
mucosa with reactive lymphoid hyperplasia.
Case presentation
A 72-year-old female was referred to our hospital after
having experienced fever and abdominal pain for 5 days
and a skin rash for 3 days before admission. She also
complained of polyarthralgia, predominantly on her dis-
tal extremities. At admission, her body temperature was
38.8°C and she had a skin rash composed of exudative
maculopapules and erythema multiforme over most of
her body. Based on a consultation with a dermatologist
who made a tentative diagnosis, we suspended loxo-
profen and famotidine, medications she had been taking,
because of the suspicion that the eruptions may have
been drug-induced. Concomitantly, she received anti-
biotic therapy (meropenem) under adequate hydration,
and underwent repeated blood and stool cultures. La-
boratory data showed systemic inflammatory response
represented by an increased WBC, 7380/μL, and mo-
derately elevated CRP, 7.74 mg/dL. Her computed tomo-
graphy (CT) scan demonstrated thickening of mucosa
and enlarged mesenteric lymph nodes (Figure 1). A col-
onoscopy examination showed a round mucosal ele-
vation with hemorrhagic erosion and ulceration at the
terminal ileum and cecum (Figure 2), for which the
pathological finding was suspicious malignant lymphoma
with an infiltration of atypical lymphocytes into necrotic
mucosa (Figure 3). Immunohistochemistry determined
CD3+ T-cell distribution in the submucosal tissue, but
did not confirm clonality of lymphocytes. Based on the
pathology results, we performed an 18-fluoro-deoxyglu-
cose positron emission tomography (FDG-PET)/CT
scan, which drew an accumulation of FDG isotopes into
regional mesenteric lymph nodes (SUV max 2.6). In
addition, an increased level of soluble interleukin-2
receptor (sIL-2R), 3095 IU/mL, and an expansion of a
lymphocyte subset expressing γδ T-cell receptor in pe-
ripheral blood and bone marrow (10.9% and 3.9%,
respectively) supported the diagnosis of malignant
lymphoma. These results led to a tentative diagnosis
of enteropathy-associated T-cell lymphoma (EATL, or
γδT-cell lymphoma). The patient’s febrile and abdominal
symptoms ameliorated rapidly a few days after anti-
biotics were initiated, and her skin eruptions improved
over the following 7 days.
Since we could not obtain a confirmation of the patho-
logical diagnosis, we reevaluated all aberrant clinical
findings after the remission of the patient’s symptoms.
Within the 2-week treatment course, her laboratory data
recovered to normal ranges. The sIL-2R level decreased
to 483 IU/mL, and γδ T cells in peripheral blood were
almost nonexistent (0.04%). A CT scan and colonoscopy
conducted a few weeks after onset revealed slight swell-
ing of the mesenteric lymph nodes and completely
normal mucosa. During the second evaluation of the ten-
tative diagnosis, Yersinia pseudotuberculosis was identified
from her stool culture at admission. In light of all of
the findings, we made the final diagnosis of Yersinia
enterocolitis.
Conclusion
Most Yersinia infection is self-limiting pathogenesis, and
in our patient the symptoms improved dramatically imme-
diately after initiation of treatment with a broad antimicro-
bial, meropenem. Management of Yersinia enteroclolits
requires antimicrobials and adequate symptom-based
Figure 1 Her abdominal and pelvic enhanced CT revealed
mucosal thickness of cecum (circle) and enlarged lesional
lymph node (arrows). Left panel indicates transverse imaging and
right panel indicates coronal imaging.
Figure 2 Colonoscopy showed hemorrhagic erosion and
ulceration (arrows) at terminal ileum (left) and cecum (right).
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supportive care to avoid unfavorable complications such
as dehydration. First-line drugs used against the bacterium
include aminoglycosides and trimethoprim-sulfametho-
xazole (TMP-SMZ). Microbiologically, pathogenesis of
Yersinia depends on virulence against mucosal tissue that
produces a necrotic consequence for the infected host.
When encountering a patient with symptoms derived from
febrile enterocolitis with or without skin eruption, clini-
cians should differentiate infectious enterocolitis from
other immunogenic or malignant diseases. Causative pa-
thogens of infectious enterocolitis presenting local inflam-
matory change at the cecum and terminal ileum include
Mycobacterium tuberculosis, Salmonella (typhi and para-
chyphi), Campylobacter, and Yersinia. Invasive suppurative
enterocolitis such as Yersinia can sometimes mimic other
noninfectious pathogenicity, such as autoimmune diseases
[1], inflammatory bowel diseases (Crohn’s disease) [2] and
malignancies [3]. In this case, a differential diagnosis in-
cluded infectious enterocolitis from other immunogenic or
malignant diseases. A measurement of sIL-2R is critical in
differentiating malignant lymphoma in patients suffering
with lymph adenopathy.
Over the past 20 years, a wide range of clinical manifes-
tations of Yersinia enterocolitis has been revealed, and in-
creased knowledge has been gained about this infection.
The mechanism underlying the immunological reaction
against Yersinia, however, remains obscure. The virulence
of Yersinia organisms is associated with the enzymatic
protein Yersinia protein kinase (Ypk), the production of
which results in invasive suppurative infection of the
lymph nodes [4]. The question of whether specific T lym-
phocytes are involved in the immune defense against
Yersinia might be related to the mechanisms under-
lying this infection’s extraintestinal manifestations and
autoimmune-like sequelae, such as erythema nodosum,
uveitis, and arthritis.
Autenrieth et al. demonstrated a specific T-cell reaction
to Yersinia infection in a mouse-infection model [5]. In
their phenotypic characterization of reactive T-cell clones
on days 14, 20, and 24 after infection of Yersinia in
C57BL/6 mice, they did not detect T cells positive for γδ
T-cell receptors, but all T cells were positive for IL-2R.
This result suggests that γδ T cells may no longer have
been detectable in a subacute phase reaction at least 14
days after Yersinia infection. Autenrieth et al. isolated and
identified specific T-cell clones at 12 to 14 days after
restimulation by Yersinia antigens, and found that these T
cells specifically produced a considerable amount of INF-γ
but not IL-2. These cells were both CD8 (Lyt2) or CD4
(L3T4)-positive. In fact, CD8 or CD4 T-cell induction by
Yersinia infection is supported by the same mouse model
[6]. In the Bühler study, the authors purified Yersinia
enterocolitica microparticles, including invasive protein
(invasin), and observed both enhanced CD4 and CD8
T-cell responses. They contended that invasion might
promote a suitable inflammatory host response, and des-
cribed the attractive possibility of an invasin vaccination
against challenges by other pathogenic entero-organisms.
Although the deficiency of γδ T-cell reaction for Yersinia
infection was reported in the subacute infection mouse
model, Young et al. demonstrated an expression of γδ
T-cell receptors 7 to 10 days after stimulation by Yersinia-
infected autologous B cells [7]. They further elicited the
killing ability of generated γδ T-cell lines against Yersinia-
infected target cells, even though γδ T-cells were
generated in concert with autologous synovial fluid mono-
nuclear cells in a major histocompatibility complex
(MHC)-independent manner. Young proposed that the
participation and contribution of the γδ T-cell response
attenuates immunopathological mechanisms of reactive
arthritis after Yersinia infection. From the Young experi-
ment, we learned that in the early phase, 7–10 days after
Yersinia infection, γδ T-cells can proliferate and enhance
local immunologic reaction in synovia.
In our patient, γδ T cells not only circulated in the
peripheral blood but also infiltrated into bone marrow.
There may be an effect of γδ T cells on the establish-
ment of tuberculosis-like or lymphoma-like pathology
with inflammatory cell responses. Although the im-
munological role of this T-cell subset phenotypically
positive for γδ T-cell receptor is still under investigation,
the reaction by these identical T-cell lines to the Yersinia
organism would explain the multifocal pathology both in
situ and at extraintestinal sites. This patient’s case indi-
cates that T cells expressing the γδ T-cell receptor might
be associated with the acute and late phase reactions, in
which T cells play a role in the construction of granu-
lomas and the establishment of sequelae.
Figure 3 Histopathological findings were compatible of
malignant lymphoma of colon mucosa, where small atypical
lymphocytes (positive for CD3 and CD5) with cleaved nuclear
infiltrate in intra-tubular submucosal area.
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